We are live on ! Find out more
QC

Quantedge Capital Portfolio holdings

AUM $183M
1-Year Est. Return 37.27%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
+37.27%
3 Year Est. Return
+101.13%
5 Year Est. Return
+161.06%
10 Year Est. Return
AUM
$210M
AUM Growth
+$27.1M
Cap. Flow
+$27.8M
Cap. Flow %
13.23%
Top 10 Hldgs %
61.64%
Holding
96
New
28
Increased
21
Reduced
21
Closed
25

Top Buys

Rank Stock Value
1
BWA icon
BorgWarner
BWA
+$11.2M
2
PVH icon
PVH
PVH
+$9.36M
3
WYNN icon
Wynn Resorts
WYNN
+$5.8M
4
TNK icon
Teekay Tankers
TNK
+$4.99M
5
YELP icon
Yelp
YELP
+$4.98M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.87%
2 Consumer Staples 17.22%
3 Healthcare 16.42%
4 Industrials 4.64%
5 Energy 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PVH icon
1
PVH
PVH
$3.6B
$31.5M 15.01%
470,000
+119,700
+34% +$9.36M
HLF icon
2
Herbalife
HLF
$1.24B
$29M 13.82%
2,249,683
+111,700
+5% +$1.18M
BWA icon
3
BorgWarner
BWA
$12.8B
$16.4M 7.8%
363,400
+255,100
+236% +$11.2M
ADNT icon
4
Adient
ADNT
$1.55B
$14.7M 7.02%
768,411
-291,700
-28% -$6.14M
YELP icon
5
Yelp
YELP
$1.44B
$7.31M 3.48%
240,400
+161,400
+204% +$4.98M
BLBD icon
6
Blue Bird Corp
BLBD
$2.48B
$6.69M 3.19%
142,300
+9,000
+7% +$471K
GIII icon
7
G-III Apparel Group
GIII
$1.49B
$6.5M 3.1%
224,416
-43,000
-16% -$1.23M
BTX
8
BlackRock Technology and Private Equity Term Trust
BTX
$935M
$5.85M 2.79%
887,079
+731,750
+471% +$4.92M
TNK icon
9
Teekay Tankers
TNK
$2.43B
$5.76M 2.74%
107,818
+88,918
+470% +$4.99M
WYNN icon
10
Wynn Resorts
WYNN
$10B
$5.65M 2.69%
+46,919
New +$5.8M
CALY
11
Callaway Golf Company
CALY
$3.48B
$5.24M 2.5%
449,200
+272,700
+155% +$2.88M
SUPN icon
12
Supernus Pharmaceuticals
SUPN
$2.79B
$4.45M 2.12%
89,600
-31,500
-26% -$1.53M
STEW
13
SRH Total Return Fund
STEW
$1.76B
$4.28M 2.04%
231,103
+10,500
+5% +$189K
BIO icon
14
Bio-Rad Laboratories Class A
BIO
$8.15B
$4.28M 2.04%
14,140
-11,660
-45% -$3.64M
COUR icon
15
Coursera
COUR
$1.59B
$4.17M 1.99%
566,800
+349,500
+161% +$3.04M
INMD icon
16
InMode
INMD
$889M
$3.72M 1.77%
252,900
-23,900
-9% -$352K
TXG icon
17
10x Genomics
TXG
$5.55B
$3.33M 1.59%
+203,953
New +$3.08M
MEDP icon
18
Medpace
MEDP
$15.4B
$2.97M 1.41%
+5,280
New +$3M
UNFI icon
19
United Natural Foods
UNFI
$2.97B
$2.96M 1.41%
88,000
-181,500
-67% -$6.75M
STOK icon
20
Stoke Therapeutics
STOK
$1.81B
$2.77M 1.32%
87,200
+47,200
+118% +$1.42M
NOV icon
21
NOV
NOV
$7.01B
$2.71M 1.29%
+173,200
New +$2.57M
AMPH icon
22
Amphastar Pharmaceuticals
AMPH
$871M
$2.46M 1.17%
91,700
+46,600
+103% +$1.2M
HRMY icon
23
Harmony Biosciences
HRMY
$1.96B
$2.29M 1.09%
61,300
-3,400
-5% -$112K
ASND icon
24
Ascendis Pharma A/S
ASND
$17.1B
$1.96M 0.93%
9,200
+2,100
+30% +$434K
FIGS icon
25
FIGS
FIGS
$1.72B
$1.93M 0.92%
170,200

Similar funds

Quantedge Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Quantedge Capital held 96 positions worth $210M, up 15% from $183M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Quantedge Capital deployed $27.8M of net new capital in Q4 2025, opening 28 new positions and adding to 21 existing holdings. Its largest new stake was Wynn Resorts: 46,919 shares worth $5.65M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 41% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was United Natural Foods, an estimated $6.75M trimmed.

  • Quantedge Capital's largest Q4 2025 buy was Wynn Resorts: 46,919 shares worth $5.65M.
  • Quantedge Capital added most to BorgWarner in Q4 2025, an estimated $11.2M increase.
  • Quantedge Capital's biggest Q4 2025 reduction was United Natural Foods, cutting an estimated $6.75M.
  • Quantedge Capital fully exited DNOW Inc in Q4 2025, selling an estimated $5.36M.
  • Quantedge Capital's ten largest holdings make up 62% of its $210M portfolio in Q4 2025.
  • Quantedge Capital opened 28 new positions and closed 25 in Q4 2025.
  • Quantedge Capital's portfolio value rose 15% quarter-over-quarter to $210M.

Based on Quantedge Capital's 13F filing for Q4 2025, filed 17 Feb 2026.